apolipoprotein C2
| UniProt | Protein Name |
|---|---|
| A0A024R0T9 |
|
| P02655 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| lipid metabolic process |
|
|
| lipid transport |
|
|
| positive regulation of triglyceride catabolic process |
|
|
| positive regulation of very-low-density lipoprotein particle remodeling |
|
|
| negative regulation of very-low-density lipoprotein particle clearance |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein binding |
|
|
| enzyme activator activity |
|
|
| lipid binding |
|
|
| phospholipase activator activity |
|
|
| phospholipase activator activity |
|
| InterPro |
|---|
| ApoC-II domain superfamily |
| Apolipoprotein C-II |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111418 | familial apolipoprotein C-II deficiency | |
| DOID:1168 | familial hyperlipidemia | |
| DOID:2377 | multiple sclerosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026